Some of the refined products from petroleum are chemicals that make it into our modern world as polymers (imagine plastics), but the degradability of these polymers are well documented. One such synthetic polymer are super absorbent polymers (SAP). The global market of SAPs alone is $9 billion, for use in disposable personal hygiene products like […]
There’s thousands of ways that cells become unhealthy. But until 2012, there were only two ways that cells actually die. That year, the cofounder of Prothegen, Dr. Scott Dixon, discovered a new way cells die, called ferroptosis, an iron-mediated failure of antioxidant defenses. Now Dixon has partnered with Roche alum Davide Zanchi and chemist Derek […]
To reach the full potential of RNA therapeutics, we have to understand how the tuning of just 4 ingredients in the delivery vehicle (lipid nanoparticles) can confer transfection and targeting efficiency. Dandelion is the first to leverage machine learning and biophysics in a systematic attempt to make sense of the chaos between LNP structure and […]
west~bourne was the first certified zero-waste restaurant in NYC. Now the founder Camilla Marcus is in LA, where she has created the world’s first zero-waste packaged goods brand, sourcing exclusively from farms that deploy regenerative agriculture. Their baking mixes, tasty snacks, and yummy sauces are quickly winning awards and prominent distribution. As regenerative ag practices […]
Pesticides are always a compromise: if you kill the mosquitos, you end up killing the bees too. Pyrone discovered a rare natural compound that controls mosquitos and other pests not by killing them, but by temporarily stunning them. Already fast-tracked by the EPA and being tested by the USDA in Gainesville, Pyrone is now scaling […]
Plant based chicken wings — with a signature crispy skin
Revealing the undetectable through single-shot multi-omics.
Invest in IndieBio Companies
Companies Raising Now
Every season of the year, a new batch and about one-sixth of our alumni are in raise mode. The companies above are currently raising and would love to talk to interested investors. We can set up those meetings or you can contact the companies directly.
Don’t wait for Demo Day!
We encourage our startups to meet with investors during our programs. We announce our new startups a month into the program, and for the next 100 days we expose them in many ways – from 1:1 meetings, pitch practice days, and investor speed dates. A majority of our startups have soft-pencilled full rounds prior to Demo Day. Let us know if you are interested!
Investing with SOSV
IndieBio / SOSV shares a cap table with over 430 funds for the IndieBio portfolio alone. SOSV’s complete network is far larger. Lets us know if you would like to know more about investing with SOSV in biotech, hard tech and Asia cross-border. We love to meet new VCs.
Backing Life Science Founders
The Genesis Consortium is an alliance of VCs and corporates, founded by IndieBio and Mayfield, committed to human and planetary evoluition.
You are in Good Company
Share a Cap Table
We work with hundreds of global corporates, and their CVCs, and we are open to anyone who has innovation onramps designed to facilitate rapid experimentation. We welcome site visits and will take great care of you. Our top priority is speed, but trust is a prerequisite. Every successful IndieBio alumni has great relationships with corporate partners, be they an investor, a supplier, a manufacturer, or a customer.
What works well:
Master-MTAs, standardized two-ways NDAs, no-rights experiments/trials, pilot projects, CVCs with dry powder, and access to real decision-makers, not just gatekeepers.
What doesn’t work:
Exclusivity without upfronts, multi-level decision making, specialized agreements that take extensive legal review to start work, and in-house champions who don’t have bandwidth for new projects.